Santa Cruz Biotechnology provides a broad selection of CD45R monoclonal antibodies for advanced research in immunology and cell biology. CD45R monoclonal antibodies excel in various applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD45R, also known as B220, plays a vital role in regulating immune cell signaling and activation, particularly in B lymphocytes. The protein's function in modulating T and B cell responses makes CD45R a key target for understanding immune system function and the development of immune-related diseases. CD45R research continues to reveal new insights about immune cell development and differentiation. Understanding CD45R mechanisms has become increasingly important for developing new therapeutic approaches. The investigation of CD45R is fundamental for advancing therapeutic strategies in autoimmune disorders and cancer immunotherapy. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to make meaningful contributions to immunology research and therapeutic development.